跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-NAPROXEN TABLET 250 MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-NAPROXEN TABLET 250 MG
Approved
THERAPEUTIC
APO-NAPROXEN TABLET 250 MG
APOTEX INC (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Jan 8, 1991
Approval ID
d96dff09bc88c1d3
Company
APOTEX INC (CANADA)
Type
Therapeutic
Approval Details
Approval Id
d96dff09bc88c1d3
Drug Name
APO-NAPROXEN TABLET 250 MG
Product Name
APO-NAPROXEN TABLET 250 MG
Approval Number
SIN05295P
Approval Date
1991-01-08
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
M01AE02
Atc Item Name
naproxen
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
NAPROXEN
250 mg
NAPROXEN
250 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 8, 1991
Approval ID
d96dff09bc88c1d3
Type
Therapeutic
Back to HSA Approvals